Arterys, a premier medical imaging platform, today announced a partnership with DeepLook Medical to improve efficiency and consistency in the oncology workflow. The Arterys platform will now offer DL Precise, our one-click segmentation and measurement utility. Arterys will demo DL Precise in its booth (#4719) at next week’s RSNA 2022 radiology trade show in Chicago.
Arterys obtained the first-ever FDA clearance of a DL/AI model and developed the first internet platform for medical imaging. The platform helps enable physicians to make near real-time, data-driven decisions to enhance patient care and facilitate pharmaceutical research. Arterys was recently acquired by Tempus, a technology company advancing precision medicine through the practical application of AI in healthcare – and with one of the world’s largest libraries of clinical and molecular data. Read more here.
.